Claire A. Collins, NP

Claire Collins practices at Trustees of Columbia University in the City of New York in New York, New York.

Claire Collins' NPI, 1104036342, was assigned on May 23, 2007. Claire Collins holds New York license 333890.

Claire Collins' primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Claire Collins' primary practice is Trustees of Columbia University in the City of New York in New York, New York. Claire Collins is also affiliated with The Valley Hospital. The medical group on file is ColumbiaDoctors. Dmand AI also links Claire Collins to 2 more hospitals, 4 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Claire Collins practices, 8 sites in all. Vendor and product names are available with a free account.

Family is Claire Collins' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Claire Collins is licensed in New York.

Dmand AI lists acute skin infection, alzheimer's disease, asthma, chronic diabetes, chronic kidney disease, chronic obstructive pulmonary disease (COPD), chronic sinusitis and contact dermatitis among the conditions Claire Collins treats.

CMS data shows 1,163 Medicare services from Claire Collins across 13 procedure codes in 2024, for 458 Medicare patients. Medicare paid $92,230 for them. Every service was in an office.

CMS counts 458 Medicare patients who saw Claire Collins in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Claire Collins' median patient age at 60, with 66% women.

In 2024, Claire Collins wrote 2,466 Medicare Part D claims for 421 patients. 91% of them were for generic drugs. CMS names the drug for 1,970 of them, across 57 drugs with 11 or more claims each, at $96,177 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Claire Collins for performance year 2024, reported through an alternative payment model (APM). Claire Collins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Claire Collins as offering telehealth.

CMS Open Payments shows 2 general payments to Claire Collins from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $118.